Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Pan IIT Alumni India Welcomes PM Modi’s Visit to IIT Kharagpur for Platinum Jubilee Celebrations

November 21, 2026

‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27

November 21, 2026

The Ambiente Brings Luxury Handmade Rugs and Carpets Online to Homes Across India

November 21, 2026
Facebook X (Twitter) Instagram
Trending
  • Pan IIT Alumni India Welcomes PM Modi’s Visit to IIT Kharagpur for Platinum Jubilee Celebrations
  • ‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27
  • The Ambiente Brings Luxury Handmade Rugs and Carpets Online to Homes Across India
  • ‘Mere Mahavir 3.1 – Mahavir Nirvana Katha’ Concludes on a Grand Spiritual Note at Bharat Mandapam
  • HydraSure’s Gen Z Team Turns GTA VI Launch Day Into a Giveaway – Planned and Live in 24 Hours
  • Kingston Debuts at Embedded World India, Deepening Its B2B Push in India’s Enterprise and Industrial Markets
  • Heart and Lung Transplant Recipients Share Stories of a New Life at KIMS Patient Meet in Indore
  • Rahul Gupta: 10 Years of Selfless Service, Compassion and Humanity
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Business»Sanjivani Parenteral Limited Reports Q1 FY27 Results; EBITDA stood at Rs. 43.21 Mn with PAT at Rs. 24.91 Mn
Business

Sanjivani Parenteral Limited Reports Q1 FY27 Results; EBITDA stood at Rs. 43.21 Mn with PAT at Rs. 24.91 Mn

Arjun SinghBy Arjun SinghAugust 15, 2026No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Mumbai (Maharashtra) [India], August 14: Sanjivani Paranteral Limited (Sanjivani, The Company) (BSE: 531569), one of the emerging players in the pharmaceutical and healthcare manufacturing sector, continued to strengthen its operational performance during the year through improved efficiencies, focused execution, and a customer-centric approach across its business segments, and has announced its Unaudited Financial Results for Q1 FY27.K

Key Consolidated Financial Highlights

Highlights

Q1 FY27:

  • Total Income of ₹239.90 Mn, YoY growth of 33.81%
  • EBITDA of ₹43.21 Mn, YoY growth of 61.04%
  • EBITDA Margin of 18.01%, YoY growth of 305 Bps
  • Net Profit of ₹24.91 Mn, YoY growth of 43.94%
  • Net Profit Margin of 10.38%, YoY growth of 73 Bps 
  • EPS of ₹2.03, YoY growth of 43.97%

Segment-wise Performance: 

  • Injectables: Revenue stood at ₹110.12 Mn, contributing 56.59% of revenue from operations, YoY growth of 22.54% 
  • Tablets: Revenue stood at ₹84.28 Mn, contributing 43.32% of revenue from operations 
  • Nutraceuticals: Revenue stood at ₹0.18 Mn, accounting for 0.09% of revenue from operations 

Market-wise Performance: 

  • Exports (incl. incentives): Contributed 90.50% of revenue from operations (₹176.10 Mn), YoY growth of 33.49%, while domestic accounted for 9.50% (₹18.49 Mn) 
  • Core markets (Latin America, CIS, Middle East & Africa): Contributed 90.50% of revenue from operations, amounting to ₹176.10 Mn, YoY growth of 33.49%

Commenting on the performance, Mr. Ashwani Khemka, Chairman & Managing Director of Sanjivani Paranteral Limited said, “Q1 FY27 was marked by a positive start for Sanjivani Parenteral, supported by a recovery in exports and continued operational focus. The Pune IV Fluid facility is witnessing a gradual scale-up, with increasing commercialization and customer traction, while our core formulations business remains resilient.These operational developments were complemented by healthy financial performance during the quarter. Total Income registered a 33.81% YoY growth, while EBITDA increased 61.04% YoY, with EBITDA margin improving by 305 Bps to 18.01%, reflecting improved operating efficiencies and stronger business performance. Net Profit grew 43.94% YoY during the quarter, with PAT margin improving to 10.38%.Going forward, we remain focused on strengthening our manufacturing capabilities, expanding our product portfolio and enhancing our presence across domestic and international markets. We will continue to leverage improving operational efficiencies, growing customer traction and market opportunities to drive sustainable growth and create long-term value for our stakeholders.”

About Sanjivani Paranteral Limited                                                

Sanjivani Parenteral Limited (BSE: 531569) is engaged in the pharmaceutical and healthcare manufacturing business, with a focus on delivering quality products and maintaining strong operational standards. The Company continues to strengthen its presence through operational excellence, customer-centric execution, and continuous focus on quality and compliance.

With a commitment towards sustainable growth and long-term value creation, the Company continues to focus on enhancing manufacturing capabilities, improving efficiencies, and expanding its business presence across key markets.

For FY26, the company has reported Total Income of ₹ 697.56 Mn, EBITDA of ₹ 114.00 Mn & PAT of ₹ 66.94 Mn on consolidated basis.

Disclaimer: This article is for informational purposes only and does not constitute financial advice.

Business
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Arjun Singh
  • Website

Related Posts

‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27

November 21, 2026

The Ambiente Brings Luxury Handmade Rugs and Carpets Online to Homes Across India

November 21, 2026

Kingston Debuts at Embedded World India, Deepening Its B2B Push in India’s Enterprise and Industrial Markets

November 21, 2026

Comments are closed.

Top Posts

‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27

November 21, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Don't Miss
National

Pan IIT Alumni India Welcomes PM Modi’s Visit to IIT Kharagpur for Platinum Jubilee Celebrations

By Arjun SinghNovember 21, 2026

Kharagpur (West Bengal) [India], November 21: Pan IIT Alumni India has welcomed Prime Minister Narendra…

‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27

November 21, 2026

The Ambiente Brings Luxury Handmade Rugs and Carpets Online to Homes Across India

November 21, 2026

‘Mere Mahavir 3.1 – Mahavir Nirvana Katha’ Concludes on a Grand Spiritual Note at Bharat Mandapam

November 21, 2026
Most Popular

‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27

November 21, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

Pan IIT Alumni India Welcomes PM Modi’s Visit to IIT Kharagpur for Platinum Jubilee Celebrations

November 21, 2026

‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27

November 21, 2026

The Ambiente Brings Luxury Handmade Rugs and Carpets Online to Homes Across India

November 21, 2026

Type above and press Enter to search. Press Esc to cancel.